BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7489359)

  • 61. [Diagnosis and clinical significance of disseminated tumor cells in bone marrow].
    Braun S; Pantel K
    Dtsch Med Wochenschr; 2000 Oct; 125(41):1237-9. PubMed ID: 11076263
    [No Abstract]   [Full Text] [Related]  

  • 62. Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.
    Vlems FA; Wobbes T; Punt CJ; Van Muijen GN
    Anticancer Res; 2003; 23(1B):523-30. PubMed ID: 12680140
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
    Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
    Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating tumour cells in cancer patients: challenges and perspectives.
    Pantel K; Alix-Panabières C
    Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.
    Braun S; Rosenberg R; Thorban S; Harbeck N
    Semin Surg Oncol; 2001 Jun; 20(4):334-46. PubMed ID: 11747276
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
    Diel IJ; Cote RJ
    Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
    Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
    Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer.
    Janni W; Rjosk D; Braun S
    Clin Breast Cancer; 2000 Oct; 1(3):217-25. PubMed ID: 11899646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow.
    Schlimok G; Riethmüller G
    Semin Cancer Biol; 1990 Jun; 1(3):207-15. PubMed ID: 2103496
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comprehensive review of solid tumor bone marrow metastasis.
    Zhang L; Chen F; Xu L; Li N; Zhuo Q; Guo Y; Wang X; Wen M; Zhao Z; Li M
    Crit Rev Oncol Hematol; 2024 Feb; 194():104248. PubMed ID: 38145832
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer.
    Heiss MM; Allgayer H; Gruetzner KU; Funke I; Babic R; Jauch KW; Schildberg FW
    Nat Med; 1995 Oct; 1(10):1035-9. PubMed ID: 7489359
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?
    Allgayer H; Aguirre-Ghiso JA
    APMIS; 2008; 116(7-8):602-14. PubMed ID: 18834405
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective.
    Vlems FA; Ruers TJ; Punt CJ; Wobbes T; van Muijen GN
    Eur J Surg Oncol; 2003 May; 29(4):289-302. PubMed ID: 12711279
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The biology and analysis of single disseminated tumour cells.
    Klein CA
    Trends Cell Biol; 2000 Nov; 10(11):489-93. PubMed ID: 11050421
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.
    Vincent-Salomon A; Bidard FC; Pierga JY
    J Clin Pathol; 2008 May; 61(5):570-6. PubMed ID: 18037661
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A new approach to phenotyping disseminated tumor cells: methodological advances and clinical implications.
    Noack F; Schmitt M; Bauer J; Helmecke D; Krüger W; Thorban S; Sandherr M; Kuhn W; Graeff H; Harbeck N
    Int J Biol Markers; 2000; 15(1):100-4. PubMed ID: 10763150
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.